Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 7 studies | 32% ± 19% | |
epithelial cell | 6 studies | 32% ± 6% | |
basal cell | 4 studies | 28% ± 15% | |
astrocyte | 4 studies | 25% ± 6% | |
squamous epithelial cell | 3 studies | 44% ± 18% | |
ciliated cell | 3 studies | 18% ± 2% | |
retinal rod cell | 3 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 29% ± 0% | |
glutamatergic neuron | 3 studies | 33% ± 5% | |
intestinal crypt stem cell | 3 studies | 17% ± 0% |
Insufficient scRNA-seq data for expression of ABHD17C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1435.65 | 244 / 245 | 99% | 53.60 | 498 / 502 |
brain | 99% | 1278.45 | 2624 / 2642 | 99% | 34.98 | 698 / 705 |
lung | 100% | 2230.62 | 577 / 578 | 97% | 62.99 | 1126 / 1155 |
bladder | 95% | 917.05 | 20 / 21 | 96% | 58.90 | 484 / 504 |
esophagus | 91% | 1883.84 | 1312 / 1445 | 100% | 81.65 | 183 / 183 |
thymus | 100% | 824.04 | 652 / 653 | 86% | 27.45 | 523 / 605 |
pancreas | 90% | 383.51 | 295 / 328 | 96% | 70.10 | 171 / 178 |
intestine | 87% | 2072.84 | 836 / 966 | 99% | 97.19 | 523 / 527 |
stomach | 86% | 1260.83 | 310 / 359 | 98% | 85.87 | 281 / 286 |
skin | 100% | 1727.65 | 1809 / 1809 | 75% | 23.64 | 354 / 472 |
breast | 76% | 482.81 | 351 / 459 | 94% | 34.11 | 1046 / 1118 |
uterus | 60% | 301.09 | 102 / 170 | 95% | 58.44 | 437 / 459 |
kidney | 100% | 934.65 | 89 / 89 | 29% | 5.75 | 260 / 901 |
ovary | 32% | 105.49 | 57 / 180 | 92% | 25.16 | 394 / 430 |
adrenal gland | 95% | 492.96 | 245 / 258 | 23% | 4.30 | 54 / 230 |
spleen | 100% | 840.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.34 | 1 / 1 |
liver | 67% | 274.65 | 151 / 226 | 28% | 6.34 | 113 / 406 |
lymph node | 0% | 0 | 0 / 0 | 69% | 14.49 | 20 / 29 |
adipose | 46% | 165.11 | 549 / 1204 | 0% | 0 | 0 / 0 |
heart | 33% | 113.95 | 287 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 32% | 113.70 | 431 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 3.25 | 20 / 80 |
peripheral blood | 17% | 72.57 | 162 / 929 | 0% | 0 | 0 / 0 |
muscle | 6% | 20.25 | 48 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905668 | Biological process | positive regulation of protein localization to endosome |
GO_1902817 | Biological process | negative regulation of protein localization to microtubule |
GO_0002084 | Biological process | protein depalmitoylation |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0010008 | Cellular component | endosome membrane |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0005515 | Molecular function | protein binding |
GO_0008474 | Molecular function | palmitoyl-(protein) hydrolase activity |
Gene name | ABHD17C |
Protein name | Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22) Abhydrolase domain containing 17C, depalmitoylase |
Synonyms | FAM108C1 |
Description | FUNCTION: Hydrolyzes fatty acids from S-acylated cysteine residues in proteins. Has depalmitoylating activity towards NRAS and DLG4/PSD95. . |
Accessions | ENST00000560609.1 ENST00000258884.5 [Q6PCB6-1] H0YN98 ENST00000558464.1 [Q6PCB6-2] Q6PCB6 |